Ridgepath Capital Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$251K Sell
1,725
-2
-0.1% -$293 0.14% 55
2026
Q2
$253K Sell
1,727
-131
-7% -$19.1K 0.11% 48
2026
Q1
$268K Buy
1,858
+11
+0.6% +$1.67K 0.13% 44
2025
Q4
$284K Hold
1,847
– – 0.13% 38
2025
Q3
$284K Buy
1,847
+10
+0.5% +$1.56K 0.12% 40
2025
Q2
$293K Buy
1,837
+10
+0.5% +$1.63K 0.13% 37
2025
Q1
$311K Buy
1,827
+10
+0.6% +$1.68K 0.15% 37
2024
Q4
$305K Buy
1,817
+9
+0.5% +$1.53K 0.14% 34
2024
Q3
$313K Buy
1,808
+9
+0.5% +$1.53K 0.25% 31
2024
Q2
$297K Buy
1,799
+9
+0.5% +$1.47K 0.29% 32
2024
Q1
$290K Buy
+1,790
New +$281K 0.33% 32

Other funds holding PG

Ridgepath Capital Management's PG Position: Q3 2026 in Review

Ridgepath Capital Management reduced its Procter & Gamble (PG) stake by 0.12% in Q3 2026, selling an estimated $293 and leaving 1,725 shares worth $251K. The position accounts for 0.14% of the portfolio, ranked #55.

Ridgepath Capital Management first reported a position in PG in Q1 2024 and has held it in 11 quarters since. The position peaked at $313K in Q3 2024. 4,008 funds tracked by Wall St. Rank hold PG as of Q3 2026.

  • Ridgepath Capital Management held 1,725 shares of Procter & Gamble worth $251K as of Q3 2026.
  • Ridgepath Capital Management sold 2 Procter & Gamble shares in Q3 2026, an estimated $293.
  • Procter & Gamble made up 0.14% of Ridgepath Capital Management's portfolio in Q3 2026, its #55 holding.
  • Ridgepath Capital Management first reported a position in Procter & Gamble in Q1 2024 and has held it in 11 quarters since.
  • Ridgepath Capital Management's Procter & Gamble position peaked at $313K in Q3 2024.
  • 4,008 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2026.

Based on Ridgepath Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.